$ENTX 3 SEC Filings

Filed On	Filing
21 Aug 2026	Form 3: Camisasca Riccardo Paolo, Chief Medical Officer No securities owned
09 Feb 2026	Form 3: Germano Geno J, Director No securities owned
05 Feb 2026	Form 3: Rubin Steven D, Director No securities owned
20 May 2025	Form 3: Gautam Leslie Velka, Chief Business Officer
20 Nov 2024	Form 3: Knoll Capital Management, Llc, 10% owner Holds 5,534,275 shares of Ordinary Shares, par value NIS 0.0000769 per share
07 Jun 2024	Form 3: Burshtein Gregory, Chief of R&D Holds 75,126 shares of Ordinary Shares, par value NIS 0.0000769 per share
24 Aug 2023	Form 3: Taitel Haya, Director No securities owned
08 Feb 2022	Form 3: Yaacov-Garbeli Dana, Israel CFO
20 Jan 2022	Form 3: Jamas Spiros, Director
14 Jan 2022	Form 3: Ellis Sean, Director
14 Jan 2022	Form 3: Malca Yonatan, Director
14 Jan 2022	Form 3: Ratan Ramesh, U.S.based CFO No securities owned
14 Jan 2022	Form 3: Santora Arthur C Ii, Chief Medical Officer
14 Jan 2022	Form 3: Galitzer Hillel, Chief Operating Officer Holds 34,106 shares of Ordinary Shares, par value NIS 0.0000769 per share
13 Jan 2022	Form 3: Ostrov Gerald M, Director
11 Jan 2022	Form 3: Toledano Miranda Jayne, Director
11 Jan 2022	Form 3: Lieberman Gerald M, Director Holds 131,918 shares of Ordinary Shares, par value NIS 0.0000769 per share
11 Jan 2022	Form 3: Schwartz Phillip, Director Holds 597,410 shares of Ordinary Shares, par value NIS 0.0000769 per share
11 Jan 2022	Form 3: Mayron Ron, Director
11 Jan 2022	Form 3: Garceau Roger, Director Holds 4,940 shares of Ordinary Shares, par value NIS 0.0000769 per share

Comments